Crossmark

Comparison of Survival Outcomes Among Patients Receiving Chemotherapy with Secondary Cytoreductive Surgery Versus Chemotherapy Alone for Recurrent Epithelial Ovarian, Tubal, or Peritoneal Carcinoma: a Propensity Score-matched Cohort Study

Crossref DOI link: https://doi.org/10.1007/s13193-025-02225-8

Published Online: 2025-02-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Singh, Anjali https://orcid.org/0000-0002-5510-104X
Penumadu, Prasanth https://orcid.org/0000-0002-2189-5056
Ganesan, Prasanth https://orcid.org/0000-0003-2762-6591
Balasubramanian, A. https://orcid.org/0000-0002-1821-589X
Chaturvedula, Latha https://orcid.org/0000-0002-6237-6551
Nair, Sreekumar https://orcid.org/0000-0002-0020-0796
Ganapathy, Sachit https://orcid.org/0000-0001-7168-0689
License Information

Text and Data Mining valid from 2025-02-06

Version of Record valid from 2025-02-06
More Information

Article History

Received: 21 July 2024

Accepted: 21 January 2025

First Online: 6 February 2025

Declarations

:

: The corresponding author (PP) is a section editor for the IJSO Journal. The other authors declare no competing interests.